Skip to main content

Table 2 Drug-likeness based on Lipinski parameters and the number of rotatable bonds of the synthetic compounds

From: Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies

Compound

MW ≤ 750

n donorHB

n accptHB

QPlogPo/w

n violations ≤ 1

#n rotor

NC1

284.311

0

3.25

3.781

0

7

NC6

314.337

0

4.00

3.871

0

8

NC7

282.338

0

2.50

4.410

0

7

NC5

326.391

0

3.25

4.538

0

8

NC2

363.207

0

3.25

4.365

0

7

NC8

269.256

0

2.75

2.786

0

6

NF2

284.311

0

4.00

3.293

0

2

NF4

312.365

0

4.00

3.988

0

3

NF5

326.391

0

4.00

4.314

0

3

NF7

269.256

0

3.75

2.337

0

1

NPC3

270.284

0

3.00

3.092

0

2

NPC5

300.310

0

4.00

3.154

0

3

NPC7

298.338

0

3.00

3.787

0

3

NPC6

312.365

0

3.00

4.115

0

3

NPC4

349.180

0

3.00

3.681

0

2

NPC8

315.282

0

4.00

2.348

0

3

NP4

256.257

1

3.00

2.382

0

2

NP5

286.284

1

4.00

2.494

0

3

NP6

298.338

1

3.00

3.361

0

3

NP9

284.311

1

3.00

3.040

0

3

NP7

335.153

1

3.00

2.949

0

2

  1. MW Molecular weight; n donorHB Number of hydrogen bond donor; n accpHB Number of hydrogen bond acceptor; QPlogPo/w Predicted octanol/water partition coefficient; #n rotor Number of rotatable bonds